Franklin Resources’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
132,301
+94,006
| +245% | +$1.25M | ﹤0.01% | 1748 |
|
|
2025
Q1 | $390K | Sell |
38,295
-250,133
| -87% | -$2.55M | ﹤0.01% | 2358 |
|
|
2024
Q4 | $4.57M | Buy |
288,428
+194
| +0.1% | +$3.07K | ﹤0.01% | 1378 |
|
|
2024
Q3 | $17.4M | Sell |
288,234
-111,980
| -28% | -$6.77M | ﹤0.01% | 934 |
|
|
2024
Q2 | $18.3M | Sell |
400,214
-231,835
| -37% | -$10.6M | 0.01% | 885 |
|
|
2024
Q1 | $41.8M | Sell |
632,049
-67,376
| -10% | -$4.46M | 0.01% | 634 |
|
|
2023
Q4 | $27.8M | Buy |
699,425
+226,674
| +48% | +$9.01M | 0.01% | 671 |
|
|
2023
Q3 | $15.1M | Hold |
472,751
| – | – | 0.01% | 818 |
|
|
2023
Q2 | $19M | Hold |
472,751
| – | – | 0.01% | 769 |
|
|
2023
Q1 | $20.2M | Hold |
472,751
| – | – | 0.01% | 763 |
|
|
2022
Q4 | $22.7M | Sell |
472,751
-247
| -0.1% | -$11.9K | 0.01% | 740 |
|
|
2022
Q3 | $17.8M | Buy |
472,998
+118
| +0% | +$4.44K | 0.01% | 796 |
|
|
2022
Q2 | $13.1M | Buy |
472,880
+78,203
| +20% | +$2.16M | 0.01% | 888 |
|
|
2022
Q1 | $21.5M | Sell |
394,677
-11
| -0% | -$598 | 0.01% | 838 |
|
|
2021
Q4 | $23.1M | Buy |
394,688
+28
| +0% | +$1.64K | 0.01% | 854 |
|
|
2021
Q3 | $15.6M | Sell |
394,660
-65
| -0% | -$2.57K | 0.01% | 949 |
|
|
2021
Q2 | $16.8M | Buy |
394,725
+134,546
| +52% | +$5.71M | 0.01% | 902 |
|
|
2021
Q1 | $16M | Buy |
260,179
+53
| +0% | +$3.26K | 0.01% | 883 |
|
|
2020
Q4 | $18.3M | Buy |
+260,126
| New | +$18.3M | 0.01% | 826 |
|